A double-blind, placebo-controlled study
β
C. R. Lines; J. H. Ambrose; A. Heald; M. Traub
π
Article
π
1993
π
John Wiley and Sons
π
English
β 612 KB
This double-blind, placebo-controlled, crossover study examined the effects of two single doses of eptastigmine, a novel cholinesterase inhibitor, on scopolamine-induced cognitive deficits in 24 healthy male volunteers. Each subject received the following treatment sequences, separated by at least 1